Mariana Quaresma de Souza, Juliana Lemos Dal Pizzol, Ana Bárbara Scholante Silva, Felipe Furtado Gomes Riet Vargas, Denise Silva Brião, Carolina Almeida Martinato, A. von Groll, P. E. Almeida da Silva, Ivy Bastos Ramis
{"title":"COVID-19大流行对巴西南部结核病实验室诊断的影响","authors":"Mariana Quaresma de Souza, Juliana Lemos Dal Pizzol, Ana Bárbara Scholante Silva, Felipe Furtado Gomes Riet Vargas, Denise Silva Brião, Carolina Almeida Martinato, A. von Groll, P. E. Almeida da Silva, Ivy Bastos Ramis","doi":"10.17058/reci.v12i2.17191","DOIUrl":null,"url":null,"abstract":"Background and objectives: to understand the impact of the COVID-19 pandemic on tuberculosis (TB) diagnosis in different settings is essential to guide the establishment of appropriate TB control strategies. This study aimed to assess the influence of COVID-19 pandemic in laboratory diagnosis of TB in patients tested and diagnosed for TB. Methods: a data survey was carried out in the database of laboratories that perform TB diagnosis for the public health system in Rio Grande city (Rio Grande do Sul, Brazil). Results: there was a decrease of 1,368 to 735 (reduction of 46.3%) in the number of patients tested for TB in public diagnostic services in 2019 and 2020, respectively, and a decrease of 197 to 119 (reduction of 39.6%) in the number of new TB cases diagnosed. In contrast, the positivity rate was 14.4% in 2019 and 16.2% in 2020. Moreover, it was observed that the laboratory that performs the diagnostic service for Primary Health Care was the most affected, when compared to Tertiary Health Care. Conclusion: as a consequence of measures to control the spread of SARS-CoV-2, there was a reduction in TB testing and in the detection of new cases, especially in Primary Health Care, where patients with less need for hospitalization are received.","PeriodicalId":42212,"journal":{"name":"Revista de Epidemiologia e Controle de Infeccao","volume":null,"pages":null},"PeriodicalIF":0.2000,"publicationDate":"2022-08-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Impact of the COVID-19 pandemic on laboratory diagnosis of tuberculosis in southern Brazil\",\"authors\":\"Mariana Quaresma de Souza, Juliana Lemos Dal Pizzol, Ana Bárbara Scholante Silva, Felipe Furtado Gomes Riet Vargas, Denise Silva Brião, Carolina Almeida Martinato, A. von Groll, P. E. Almeida da Silva, Ivy Bastos Ramis\",\"doi\":\"10.17058/reci.v12i2.17191\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Background and objectives: to understand the impact of the COVID-19 pandemic on tuberculosis (TB) diagnosis in different settings is essential to guide the establishment of appropriate TB control strategies. This study aimed to assess the influence of COVID-19 pandemic in laboratory diagnosis of TB in patients tested and diagnosed for TB. Methods: a data survey was carried out in the database of laboratories that perform TB diagnosis for the public health system in Rio Grande city (Rio Grande do Sul, Brazil). Results: there was a decrease of 1,368 to 735 (reduction of 46.3%) in the number of patients tested for TB in public diagnostic services in 2019 and 2020, respectively, and a decrease of 197 to 119 (reduction of 39.6%) in the number of new TB cases diagnosed. In contrast, the positivity rate was 14.4% in 2019 and 16.2% in 2020. Moreover, it was observed that the laboratory that performs the diagnostic service for Primary Health Care was the most affected, when compared to Tertiary Health Care. Conclusion: as a consequence of measures to control the spread of SARS-CoV-2, there was a reduction in TB testing and in the detection of new cases, especially in Primary Health Care, where patients with less need for hospitalization are received.\",\"PeriodicalId\":42212,\"journal\":{\"name\":\"Revista de Epidemiologia e Controle de Infeccao\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":0.2000,\"publicationDate\":\"2022-08-05\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Revista de Epidemiologia e Controle de Infeccao\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.17058/reci.v12i2.17191\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"INFECTIOUS DISEASES\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Revista de Epidemiologia e Controle de Infeccao","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.17058/reci.v12i2.17191","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"INFECTIOUS DISEASES","Score":null,"Total":0}
Impact of the COVID-19 pandemic on laboratory diagnosis of tuberculosis in southern Brazil
Background and objectives: to understand the impact of the COVID-19 pandemic on tuberculosis (TB) diagnosis in different settings is essential to guide the establishment of appropriate TB control strategies. This study aimed to assess the influence of COVID-19 pandemic in laboratory diagnosis of TB in patients tested and diagnosed for TB. Methods: a data survey was carried out in the database of laboratories that perform TB diagnosis for the public health system in Rio Grande city (Rio Grande do Sul, Brazil). Results: there was a decrease of 1,368 to 735 (reduction of 46.3%) in the number of patients tested for TB in public diagnostic services in 2019 and 2020, respectively, and a decrease of 197 to 119 (reduction of 39.6%) in the number of new TB cases diagnosed. In contrast, the positivity rate was 14.4% in 2019 and 16.2% in 2020. Moreover, it was observed that the laboratory that performs the diagnostic service for Primary Health Care was the most affected, when compared to Tertiary Health Care. Conclusion: as a consequence of measures to control the spread of SARS-CoV-2, there was a reduction in TB testing and in the detection of new cases, especially in Primary Health Care, where patients with less need for hospitalization are received.